First case of COVID-19 treated with tocilizumab in Iceland
A gentleman in his early fifties became ill with flu-like symptoms after vacationing abroad and was diagnosed with COVID-19 after returning to Iceland. A few days later he was admitted to the University Hospital, Landspitali, due to worsening respiratory symptoms and severe fatigue. A computed tomography scan of lthe lungs showed diffuse bilateral consolidations and ground glass changes. He developed respiratory failure and was transferred to the intensive care unit where he received further treatment, including tocilizumab (IL-6 receptor inhibitor). He subsequently showed clinical improvement and did not require endotracheal intubation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:106 |
|---|---|
| Enthalten in: |
Laeknabladid - 106(2020), 5 vom: 01., Seite 247-250 |
| Sprache: |
Isländisch |
|---|
| Weiterer Titel: |
Fyrsta meðferð með tocilizumab við COVID-19 hérlendis - sjúkratilfelli |
|---|
| Beteiligte Personen: |
Bjornsson, Aron Hjalti [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal, Humanized |
|---|
| Anmerkungen: |
Date Completed 06.05.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.17992/lbl.2020.05.581 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309513529 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309513529 | ||
| 003 | DE-627 | ||
| 005 | 20231225134058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||ice c | ||
| 024 | 7 | |a 10.17992/lbl.2020.05.581 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1031.xml |
| 035 | |a (DE-627)NLM309513529 | ||
| 035 | |a (NLM)32367812 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ice | ||
| 100 | 1 | |a Bjornsson, Aron Hjalti |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a First case of COVID-19 treated with tocilizumab in Iceland |
| 246 | 3 | 3 | |a Fyrsta meðferð með tocilizumab við COVID-19 hérlendis - sjúkratilfelli |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.05.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a A gentleman in his early fifties became ill with flu-like symptoms after vacationing abroad and was diagnosed with COVID-19 after returning to Iceland. A few days later he was admitted to the University Hospital, Landspitali, due to worsening respiratory symptoms and severe fatigue. A computed tomography scan of lthe lungs showed diffuse bilateral consolidations and ground glass changes. He developed respiratory failure and was transferred to the intensive care unit where he received further treatment, including tocilizumab (IL-6 receptor inhibitor). He subsequently showed clinical improvement and did not require endotracheal intubation | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Cytokine storm | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Tocilizumab | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a tocilizumab |2 NLM | |
| 650 | 7 | |a I031V2H011 |2 NLM | |
| 700 | 1 | |a Olafsdottir, Thorbjorg |e verfasserin |4 aut | |
| 700 | 1 | |a Thormar, Katrin Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Kristjansson, Mar |e verfasserin |4 aut | |
| 700 | 1 | |a Thorisdottir, Anna Sesselja |e verfasserin |4 aut | |
| 700 | 1 | |a Ludviksson, Bjorn Runar |e verfasserin |4 aut | |
| 700 | 1 | |a Guðmundsson, Sigurdur |e verfasserin |4 aut | |
| 700 | 1 | |a Gottfredsson, Magnus |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Laeknabladid |d 1945 |g 106(2020), 5 vom: 01., Seite 247-250 |w (DE-627)NLM078768446 |x 1670-4959 |7 nnns |
| 773 | 1 | 8 | |g volume:106 |g year:2020 |g number:5 |g day:01 |g pages:247-250 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.17992/lbl.2020.05.581 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 106 |j 2020 |e 5 |b 01 |h 247-250 | ||